SUNDAY, APRIL 30, 2017

Minnesota health department releases vaccine announcement update

The Minnesota Department of Health has announced revisions to its policy of vaccine replenishment after existing supplies are exhausted. Read More »

February predicted as peak of flu season

Forecast models released Dec. 15 by the Centers for Disease Control (CDC) indicate the apex of flu season will likely occur nationwide in February. Read More »

Researchers investigate vaccine options for common diseases

Researchers at the University of Washington and the University of Texas at Galveston are exploring the ways receptor sites in cells bind to disease and vaccine particles. Read More »

WHO optimistic for future elimination of malaria

The WHO estimates that cases of malaria have decreased in surveyed countries to the point that elimination of the disease may be possible. Read More »

Joint research group studies common flu strains

Researchers are studying statistical variations of blood samples across all age ranges, looking for immune signatures or markers of vaccines, which may indicate vaccine effectiveness against common strains of flu. Read More »

Scripps researchers study antibodies that fight HIV

Researchers at The Scripps Research Institute (TSRI) are studying the origins and ways antibodies that fight HIV develop, interact and fight HIV. Read More »

NIH outlines strategic plan, initiatives for 2016

NIH has published its strategic plan and initiatives for 2016 as a result of the solicitation of NIH advisory councils. Read More »

Stanford University researchers detail cellular marker discovery

Researchers at Stanford University have discovered a set of cellular markers that distinguish between patients with types of viral infections and those with types of bacterial infections. Read More »

Inactivated polio vaccine now available in India

Indian Union Minister for Health and Family Welfare Shri J.P. Nadda, announced Dec. 21 that an inactivated polio vaccine (IPV) is widely available in India and around the world. The vaccine, which contains live but inactive antibodies that trigger an immune response in those receiving the vaccine, is one of the most recent treatments against polio.  Read More »

USAID issues call for HIV/AIDS vaccine grant proposals

USAID has issued a call for grant proposals as of Dec. 11 for those interested in furthering research on vaccines for treatment of HIV/AIDS. The grant must focus upon vaccine engineering and development for treating HIV/AIDS, and may specialize in particular upon women infected with HIV/AIDS. The target population for the grant and research is not limited to the U.S. Read More »

Abivax announces clinical trail for HIV/AIDS vaccine

Abivax, a French pharmaceutical manufacturer, announced Dec. 21 the clinical trial of HIV/AIDS vaccine ABX464 is available. The drug “is an orally available small molecule inhibiting HIV replication through an entirely novel mechanism, which may confer significant advantages over competing drugs," Abivax Chief Executive Officer Dr. Harmut Ehrlich said. Read More »

European health officials release Ebola update

The European Centre for Disease Prevention and Control recently provided an update on the ongoing Ebola outbreak in West Africa while pointing out the importance of maintaining surveillance and immediate response abilities in the countries originally affected by the virus. The center said that as of Nov. 18, there had been 28,598 cases of Ebola virus disease related to the outbreak. Read More »

US announces initiative to combat multidrug-resistant TB

The White House announced the creation of The National Action Plan to Combat Multidrug-Resistant Tuberculosis, an initiative to target the strain of TB that has proved resistant to common courses of drug therapy and affects countries worldwide. With this initiative, attention is given to particular types of TB in a time when it has become treatable and is in decline. Read More »

Immune responses may inhibit antibody-based treatments for HIV

Researchers from the Medical University of South Carolina recently conducted studies to determine whether immune responses inhibit the results of broadly neutralizing antibody treatments that may help people with HIV infections. Read More »

Hong Kong health officials issue dengue fever update

Officials from Hong Kong's Centre for Health Protection (CHP), a branch of the Department of Health, recently published an update with the most recent number of dengue fever cases. Read More »

Brazil approves Sanofi Pasteur's dengue vaccine

Sanofi Pasteur, Sanofi’s vaccines division, recently received regulatory approval from Brazil for the company’s dengue fever vaccine, called Dengaxia, which is designed to protect people from contracting dengue fever from infected mosquitoes. Read More »

WHO to evaluate Merck's Ebola vaccine candidate

The World Health Organization (WHO) intends to evaluate the Emergency Use Assessment and Listing (EUAL) application for an investigational Ebola vaccine that has been developed by Merck. Read More »

Novel model of SIR-Network predicts dengue epidemics

A new model of SIR-Networks, shown in an article titled “SIR-Network Model And Its Application To Dengue Fever,” shows that there will soon be dengue fever epidemics based within urban regions. Read More »

Study reveals Ebola, bats wage molecular war

A recent study from the University of Colorado-Boulder, Albert Einstein College of Medicine, and the U.S. Army Medical Research Institute of Infectious Diseases has demonstrated that the Ebola virus and bats have fought a molecular war for centuries Read More »

Malaria uses inflammatory response to evade immune system

Australian scientists recently discovered that malaria parasites trigger an inflammatory response that prevents the immune system from protecting itself from malaria and its spread throughout the body. Read More »